CG
VNRX icon

Cutler Group’s VolitionRx Ltd VNRX Stock Holding History

Cutler Group’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10
Closed – – 6423
2021
Q1 		$0 Buy
+10
New +$858 ﹤0.01% 6355

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's VNRX Position: Q2 2021 in Review

Cutler Group sold out of VolitionRx Ltd (VNRX) in Q2 2021, closing a stake of 10 shares.

Cutler Group first reported a position in VNRX in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 46 funds tracked by Wall St. Rank hold VNRX as of Q2 2021.

  • Cutler Group reported no remaining VolitionRx Ltd position as of Q2 2021 after selling out during the quarter.
  • Cutler Group sold 10 VolitionRx Ltd shares in Q2 2021.
  • Cutler Group first reported a position in VolitionRx Ltd in Q1 2021 and held it in 1 quarter.
  • Cutler Group's VolitionRx Ltd position peaked at $0 in Q1 2021.
  • 46 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2021.

Based on Cutler Group's 13F filing for Q2 2021, filed 19 Jul 2021.